Foca Gene Files 144 for Getty Images Holdings Securities Sale

Foca Gene 144 Filing Summary
FieldDetail
CompanyFoca Gene
Form Type144
Filed DateMar 24, 2026
Risk Levelmedium
Pages2
Reading Time2 min
Sentimentmixed

Complexity: simple

Sentiment: mixed

Topics: insider-sale, affiliate-sale, form-144, getty-images

TL;DR

**Foca Gene is looking to sell Getty Images stock, watch for potential price movement.**

AI Summary

This 144 filing indicates that Foca Gene, a reporting entity, intends to sell securities of Getty Images Holdings, Inc. (CIK: 0001898496). While the filing confirms the intent to sell, it does not specify the number of shares or the dollar amount, making it difficult to assess the exact impact. Investors should note that insider or affiliate sales can sometimes signal a lack of confidence in the company's future prospects, potentially putting downward pressure on Getty Images' stock price.

Why It Matters

This filing signals a potential sale of Getty Images Holdings, Inc. stock by an affiliate, which could increase the supply of shares on the market and potentially impact the stock price.

Risk Assessment

Risk Level: medium — The risk is medium because while a sale is indicated, the lack of specific share count or dollar amount makes the potential impact uncertain.

Analyst Insight

Investors in Getty Images Holdings, Inc. should monitor subsequent filings or news for details on the quantity and timing of Foca Gene's proposed sale, as this could influence stock performance.

Key Players & Entities

  • Foca Gene (company) — Reporting entity proposing to sell securities
  • Getty Images Holdings, Inc. (company) — Subject company whose securities are proposed to be sold
  • 0001939048 (person) — CIK for Foca Gene
  • 0001898496 (person) — CIK for Getty Images Holdings, Inc.
  • 2026-03-24 (person) — Filing Date

FAQ

What is the purpose of this 144 filing?

This 144 filing, submitted by Foca Gene, is a 'Report of proposed sale of securities' for Getty Images Holdings, Inc., indicating an intent to sell shares.

Who is the reporting entity in this filing?

The reporting entity is Foca Gene, identified by CIK 0001939048.

Which company's securities are being proposed for sale?

The securities being proposed for sale belong to Getty Images Holdings, Inc., identified by CIK 0001898496.

When was this 144 filing submitted and accepted?

The filing was submitted and accepted on 2026-03-24.

Does this filing specify the number of shares or dollar amount Foca Gene intends to sell?

No, this specific filing document does not provide details on the number of shares or the dollar amount of securities Foca Gene intends to sell.

Filing Stats: 602 words · 2 min read · ~2 pages · Grade level 15.4 · Accepted 2026-03-24 16:17:35

Filing Documents

From the Filing

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 FORM 144 144: Filer Information Is this a LIVE or TEST Filing? LIVE TEST Submission Contact Information Name Phone E-Mail Address 144: Issuer Information Name of Issuer Getty Images Holdings, Inc. Address of Issuer 605 5th Ave. S Seattle WASHINGTON 98104 Phone (206) 925-5000 Name of Person for Whose Account the Securities are To Be Sold GENE RAYMOND FOCA See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. Relationship to Issuer Officer 144: Securities Information Title of the Class of Securities To Be Sold Name and Address of the Broker Number of Shares or Other Units To Be Sold Aggregate Market Value Number of Shares or Other Units Outstanding Approximate Date of Sale Name the Securities Exchange Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York � NY � 10004 35000 28031.50 417765616 03/24/2026 NYSE Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor: 144: Securities To Be Sold Title of the Class Date you Acquired Nature of Acquisition Transaction Name of Person from Whom Acquired Is this a Gift? Date Donor Acquired Amount of Securities Acquired Date of Payment Nature of Payment * Common 03/20/2026 Restricted stock vesting under a registered plan Issuer 35000 03/20/2026 Not Applicable * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid. Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold. 144: Securities Sold During The Past 3 Months Nothing to Report 144: Remarks and Signature Remarks Non-discretionary sale of shares to cover tax obligation from settlement of vested Restricted Stock Units. Date of Notice 03/24/2026 ATTENTION: The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. Signature /s/ Gene Foca ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

View Full Filing

View this 144 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.